MetaCap

XTL Biopharmaceuticals Ltd. ADR Company Profile

NASDAQ: XTLBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.37-0.085 (-5.84%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

XTL Biopharmaceuticals at a glance

XTL Biopharmaceuticals Ltd. ADR (NASDAQ: XTLB) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Herzliya, NY, Israel. XTL Biopharmaceuticals is led by Mr. Noam Band and employs about 4 people. At a market capitalization of $3.4 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001023549, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does XTL Biopharmaceuticals do?

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases in Israel. The company's lead drug candidate is hCDR1, which is a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. It has a licensing agreement with Yeda Research and Development Company Limited for the research, development, and commercialization of hCDR1 for various indications. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was incorporated in 1993 and is headquartered in Herzliya, Israel.

Business description based on the company's public filings.

Company information

Legal name
XTL Biopharmaceuticals Ltd. ADR
Ticker
NASDAQ: XTLB
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Noam Band
Employees
4
Headquarters
85 Medinat Hayehudim St., Herzliya, NY, Israel
Phone
972 5 4228 8897
Website
xtlbio.com
SEC CIK
0001023549

Companies similar to XTL Biopharmaceuticals

XTLB peer companies
CompanyPrice% ChgMarket capCompare
XBIOXenetic Biosciences Inc.1.40-9.09%$3.28Mvs XTLB
IMNNImunon Inc.0.5355-5.22%$3.47Mvs XTLB
APREAprea Therapeutics Inc.0.229-53.56%$3.25Mvs XTLB
NRSNNeuroSense Therapeutics Ltd.1.28+1.59%$3.19Mvs XTLB
KPRXKiora Pharmaceuticals Inc.0.7202-12.28%$3.19Mvs XTLB
MDCXMedicus Pharma Ltd.1.14-2.16%$3.16Mvs XTLB
AZTRAzitra Inc0.5168-2.75%$3.13Mvs XTLB
NCNANuCana plc ADR0.7495+4.39%$3.61Mvs XTLB

Related